We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pencil Beam Radiation Offers More Targeted Therapy with Fewer Side Effects for Lung Cancer Patients

By HospiMedica International staff writers
Posted on 16 Nov 2010
Pencil beam scanning technology, a targeted form of radiation treatment known as proton therapy, is now being used to treat patients with lung cancer.

Proton therapy's advantage over conventional forms of radiation from its ability to deliver radiation doses to a targeted tumor with remarkable precision that avoids surrounding tissue. More...
This results in fewer side effects during and after treatment, and greater tumor control. Most proton therapy patients are treated with a technique known as passive scattering, which uses apertures to shape the proton beam and deliver a uniform dose to the tumor.

Pencil beam scanning proton therapy delivers a single, narrow proton beam (which may be less than a millimeter in diameter) that is magnetically swept across the tumor, depositing radiation similar to a painter's brush, without the need to construct beam-shaping devices. This technology continues to build on the patient benefits already offered with proton therapy more targeted, higher tumor dose, shorter treatment times, reduced side effects, and increased treatment options.

"The advantage lies in the beam's capacity to approach the tumor from multiple directions, creating a "U” shape around these structures and avoiding them entirely during treatment,” said James D. Cox, M.D., professor and head of the division of radiation oncology at MD Anderson Cancer Center (Houston, TX, USA). "Pencil beam is more like a very fine airbrush. Instead of needing a brass template to define the shape, the proton beam is made ultra fine to conform to the contours and landscapes of the tumor.”

MD Anderson's Proton Therapy Center, which began treating patients in May of 2006, is the first in North America and only one of three clinical centers in the world to treat patients with pencil beam scanning technology. Additionally, MD Anderson is the first center in the world to treat lung cancer patients using pencil beam scanning proton therapy.

"The unique part about lung cancer is that it's close to the esophagus, aorta, and spinal cord, and all of these critical structures are important for the body to function,” said Joe Chang, M.D., Ph.D., associate professor in MD Anderson's department of radiation Oncology. "The proton beam provides much more conformal radiation, which means higher doses to tumors and lower dosages to critical structures nearby.”

Another advantage of pencil beam scanning proton therapy is its use in patients with recurrent disease, who have already received full doses of radiation, according to Dr. Chang. In this instance, pencil beam limits or eliminates radiation to these sensitive areas. As the therapy advances, one of the next steps is using imaging tools to predict the movement of tumors, both lung and other cancers, to offer even greater precision.

Related Links:

MD Anderson Cancer Center



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.